Christopher Regan, Lindsey E Scierka, Alan Dardik, Britt Tonnessen, Cassius Iyad Ochoa Chaar, Costin Ionescu, Edouard Aboian, Jonathan Cardella, Naiem Nassiri, Raul Guzman, Robert Attaran, Sameer Nagpal, Samit Shah, Kim G Smolderen, Carlos Mena-Hurtado
OBJECTIVES: Antiplatelet therapy is an essential element in the management of patients with arterial vascular disease. In peripheral arterial disease (PAD), dual antiplatelet therapy (DAPT), primarily clopidogrel and aspirin, is routinely prescribed following intervention. There is sparse data regarding the need for DAPT, the appropriate duration, or the heterogeneity of treatment effects for antiplatelet regimens across patients, leading to potential uncertainty and heterogeneity around treatment practices...
April 26, 2024: Vascular